Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
AVIR
Tag: AVIR
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Entry into a Material...
ME Staff 8-k
-
February 12, 2018
0
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Entry into a Material...
ME Staff 8-k
-
February 8, 2018
0
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Financial Statements and Exhibits
ME Staff 8-k
-
December 19, 2017
0
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Financial Statements and Exhibits
ME Staff 8-k
-
November 30, 2017
0
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Financial Statements and Exhibits
ME Staff 8-k
-
November 1, 2017
0
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Entry into a Material...
ME Staff 8-k
-
October 30, 2017
0
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Notice of Delisting or...
ME Staff 8-k
-
September 27, 2017
0
Aviragen Therapeutics (NASDAQ:AVIR) Files An 8-K Notice of Delisting or Failure...
ME Staff 8-k
-
September 20, 2017
0
Aviragen Therapeutics, Inc. (NASDAQ:AVIR) Files An 8-K Results of Operations and...
ME Staff 8-k
-
May 4, 2017
0
Aviragen Therapeutics (NASDAQ:AVIR) Files An 8-K Departure of Directors or Certain...
ME Staff 8-k
-
April 4, 2017
0
1
2
Page 1 of 2
/* */
// AST – IMS - [MarketExclusive_ROS]